NL8401422A - Geneesmiddeldrager, deze drager bevattende farmaceutische preparaten, werkwijze voor het bereiden van een en ander alsmede methode voor percutane therapeutische behandeling met voornoemde farmaceutische preparaten. - Google Patents

Geneesmiddeldrager, deze drager bevattende farmaceutische preparaten, werkwijze voor het bereiden van een en ander alsmede methode voor percutane therapeutische behandeling met voornoemde farmaceutische preparaten. Download PDF

Info

Publication number
NL8401422A
NL8401422A NL8401422A NL8401422A NL8401422A NL 8401422 A NL8401422 A NL 8401422A NL 8401422 A NL8401422 A NL 8401422A NL 8401422 A NL8401422 A NL 8401422A NL 8401422 A NL8401422 A NL 8401422A
Authority
NL
Netherlands
Prior art keywords
carbon atoms
component
carrier
alkyl group
formula
Prior art date
Application number
NL8401422A
Other languages
English (en)
Dutch (nl)
Original Assignee
Nitto Electric Ind Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Electric Ind Co filed Critical Nitto Electric Ind Co
Publication of NL8401422A publication Critical patent/NL8401422A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8401422A 1983-05-20 1984-05-04 Geneesmiddeldrager, deze drager bevattende farmaceutische preparaten, werkwijze voor het bereiden van een en ander alsmede methode voor percutane therapeutische behandeling met voornoemde farmaceutische preparaten. NL8401422A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49673283A 1983-05-20 1983-05-20
US49673283 1983-05-20

Publications (1)

Publication Number Publication Date
NL8401422A true NL8401422A (nl) 1984-12-17

Family

ID=23973888

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8401422A NL8401422A (nl) 1983-05-20 1984-05-04 Geneesmiddeldrager, deze drager bevattende farmaceutische preparaten, werkwijze voor het bereiden van een en ander alsmede methode voor percutane therapeutische behandeling met voornoemde farmaceutische preparaten.

Country Status (8)

Country Link
CA (1) CA1225594A (fr)
CH (1) CH657531A5 (fr)
DE (1) DE3418565C2 (fr)
DK (1) DK239984A (fr)
FR (1) FR2547503B1 (fr)
GB (1) GB2141025B (fr)
NL (1) NL8401422A (fr)
SE (1) SE8402561L (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4637930A (en) * 1984-02-08 1987-01-20 Yamanouchi Pharmaceutical Co, Ltd. Transdermal formulation of nicardipine hydrochloride
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
US4826686A (en) * 1985-12-14 1989-05-02 Boehringer Ingelheim Kg Therapeutic system
CH666621A5 (de) * 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
US4861764A (en) * 1986-11-17 1989-08-29 Macro Chem. Corp. Percutaneous absorption enhancers, compositions containing same and method of use
GB8718886D0 (en) * 1987-08-10 1987-09-16 Ici America Inc Composition
CA1334646C (fr) * 1988-04-08 1995-03-07 James Vanolden Peck Produits stimulant la penetration transdermique
JPH03236317A (ja) * 1989-12-06 1991-10-22 Sansei Seiyaku Kk ドパミン誘導体含有経皮用製剤
US5246949A (en) * 1989-12-06 1993-09-21 Sansho Co., Ltd. Preparation for endermism containing dopamine derivatives
WO1994021262A1 (fr) * 1993-03-17 1994-09-29 Alza Corporation Dispositif d'administration transdermique d'alprazolam
DE4432429A1 (de) * 1994-09-12 1996-03-14 Heinz Prahm Arzneimittel enthaltend S-Milchsäure und dessen Verwendung
US5693335A (en) * 1995-06-07 1997-12-02 Cygnus, Inc. Skin permeation enhancer composition for use with sex steroids
DE19949202A1 (de) * 1999-10-13 2001-05-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Acetylsalicylsäure und/oder Salicylsäure
EP1931417A2 (fr) * 2005-09-30 2008-06-18 Transcutaneous Technologies Inc. Systemes d'administration transdermique de medicament, dispositifs, et methodes faisant intervenir de nouveaux excipients pharmaceutiques
JP2009522011A (ja) 2005-12-30 2009-06-11 Ｔｔｉ・エルビュー株式会社 活性物質を生体界面に送達するイオントフォレーシスシステム、装置及び方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1158283A (en) * 1965-10-21 1969-07-16 Foster Milburn Company Composition to be Applied to Skin and Process for Preparing Same.
FR2001768A1 (fr) * 1968-02-12 1969-10-03 Gillette Co Compositions pour l'application topique de medicaments sur la peau
SE325667B (fr) * 1968-03-06 1970-07-06 Medisan Ab
US3472931A (en) * 1969-01-17 1969-10-14 Foster Milburn Co Percutaneous absorption with lower alkyl amides
GB1404583A (en) * 1971-10-08 1975-09-03 Vymatt Sa Urea compositions and methods of preparation thereof
GB1504302A (en) * 1974-08-23 1978-03-15 Fisons Ltd Sedative method and composition
US3957994A (en) * 1974-12-19 1976-05-18 Nelson Research & Development Company Topical anti-inflammatory composition and method of use
US3932653A (en) * 1974-12-19 1976-01-13 Nelson Research & Development Co. Composition and method for topical administration of griseofulvin
US4017641A (en) * 1975-01-31 1977-04-12 The Procter & Gamble Company Skin moisturizing compositions containing 2-pyrrolidinone
GB1538903A (en) * 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent
US4038417A (en) * 1975-06-19 1977-07-26 Nelson Research & Development Company Method for treatment of psoriasis
US4316893A (en) * 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
CA1165240A (fr) * 1980-07-09 1984-04-10 The Procter & Gamble Company Composes pharmaceutiques a usage topique
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion

Also Published As

Publication number Publication date
GB8412569D0 (en) 1984-06-20
DE3418565C2 (de) 1992-05-27
SE8402561D0 (sv) 1984-05-11
FR2547503B1 (fr) 1987-11-20
DE3418565A1 (de) 1984-11-22
GB2141025B (en) 1986-09-17
DK239984D0 (da) 1984-05-15
SE8402561L (sv) 1984-11-21
CA1225594A (fr) 1987-08-18
CH657531A5 (de) 1986-09-15
GB2141025A (en) 1984-12-12
DK239984A (da) 1984-11-21
FR2547503A1 (fr) 1984-12-21

Similar Documents

Publication Publication Date Title
CA1228027A (fr) Methode d'administration percutanee d'agents ayant une action physiologique ayant recours a un alcool comme adjuvant et a un solvant
US4710497A (en) Method for percutaneously administering physiologically active agents
US4752612A (en) Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
KR0143916B1 (ko) 약물/침투 증대제 조성물과 관련된 피부자극의 감소방법
NL8401422A (nl) Geneesmiddeldrager, deze drager bevattende farmaceutische preparaten, werkwijze voor het bereiden van een en ander alsmede methode voor percutane therapeutische behandeling met voornoemde farmaceutische preparaten.
US4593048A (en) Base composition for external preparations, pharmaceutical composition for external use and method of promoting percutaneous drug absorption
JP2930623B2 (ja) 医薬活性剤の経皮デリバリー用組成物
KR20190003535A (ko) 전달 시스템
US5128376A (en) Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator
LT3005B (lt) Tam tikru terapiskai aktyviu 4-pakeistu imidazolu panaudojimas perodiniu farmaciniu preparatu gamybai
JPH04312520A (ja) 低級アルコールを伴うｎ−脂肪族ピロリドンの多成分系による浸透性増進
NL8402045A (nl) Preparaat voor percutane toediening, dat fysiologisch aktieve stof, hulpmiddel, oplosmiddel en een diol als moderator bevat.
CN113941002B (zh) 一种小分子药物缓释递药系统
JPS58164520A (ja) 基剤組成物及び外用医薬組成物
US5183665A (en) Composition for percutaneous administration and method for enhancing percutaneous absorption of a physiologically active ingredient empolying the same
JPH111433A (ja) トルナフテ−ト含有液剤
JPS62187415A (ja) 経皮吸収促進用組成物
JPS6287528A (ja) Ｎ−アルキルモルホリン含有外皮投与用組成物
JPH031285B2 (fr)

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed